Does LANSOPRAZOLE Cause Tumour marker increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Tumour marker increased have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.0% of all adverse event reports for LANSOPRAZOLE.
5
Reports of Tumour marker increased with LANSOPRAZOLE
0.0%
of all LANSOPRAZOLE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Tumour marker increased From LANSOPRAZOLE?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LANSOPRAZOLE Cause?
Chronic kidney disease (32,517)
Acute kidney injury (16,359)
Renal failure (12,509)
End stage renal disease (9,734)
Renal injury (9,383)
Tubulointerstitial nephritis (3,860)
Death (2,517)
Gastrooesophageal reflux disease (2,482)
Off label use (2,183)
Nephrogenic anaemia (2,162)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which LANSOPRAZOLE Alternatives Have Lower Tumour marker increased Risk?
LANSOPRAZOLE vs LANTHANUM
LANSOPRAZOLE vs LANTUS
LANSOPRAZOLE vs LANTUS SOLOSTAR
LANSOPRAZOLE vs LAPATINIB
LANSOPRAZOLE vs LAPATINIB DITOSYLATE